Clinical Trials · NCT01185704
Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Enrollment
- 136
- Start date
- Nov 2008
- Locations
- 1 site, France
- Primary endpoint
- Estradiol (E2) Levels on r-hCG Day